OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 131 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $281,000 | +903.6% | 654,000 | +1213.7% | 0.00% | – |
| Q1 2016 | $28,000 | -99.5% | 49,784 | -98.6% | 0.00% | -100.0% |
| Q4 2015 | $5,999,000 | -27.8% | 3,487,511 | -11.5% | 0.01% | -18.8% |
| Q3 2015 | $8,313,000 | -63.8% | 3,939,973 | -15.2% | 0.02% | -62.8% |
| Q2 2015 | $22,994,000 | +17.6% | 4,645,302 | +86.0% | 0.04% | +16.2% |
| Q1 2015 | $19,557,000 | +241.3% | 2,497,696 | +164.2% | 0.04% | +208.3% |
| Q4 2014 | $5,730,000 | +84.8% | 945,530 | +88.5% | 0.01% | +50.0% |
| Q2 2014 | $3,100,000 | -79.8% | 501,675 | -78.7% | 0.01% | -82.2% |
| Q1 2014 | $15,326,000 | +2.3% | 2,357,872 | -11.4% | 0.04% | -4.3% |
| Q4 2013 | $14,986,000 | +701.4% | 2,661,908 | +772.4% | 0.05% | +683.3% |
| Q3 2013 | $1,870,000 | +1420.3% | 305,109 | +1349.3% | 0.01% | – |
| Q2 2013 | $123,000 | – | 21,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
| Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
| Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
| NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
| Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
| Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
| Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |